News

G&E Biotechnology successfully exhibited at 2026 VitaFoods Europe

G&E Biotechnology will exhibit at 2026 VitaFoods Europe

Commercial Times - G&E applies for Phase I clinical trial for New drug SR-T100 injection

Announcement：G&E's New Drug, SR-T100 Injection has received a consultation response from CDE, and will formally apply to the

G&E Herbal Biotechnology Co., Ltd. at Taipei Exchange Investor Conference

Search for“Important Announcements & Notices” on the MOPS

Chairman, Kou-Wha Kuo attended the ceremony and presented the 12th Outstanding Alumni Awards

Economic Daily News - G&E Biotechnology Wins Three“Foreign Investment Taiwan Top 100”Awards — Patented Technology Leading the An

G&E Biotechnology Joins International Health Expo, Expanding into the Global Market – Sept 22, 2025

Commercial Times - G&E Herbal Biotech wins three major awards in the Top 100 Foreign Investment Companies

G&E Herbal Biotechnology has been recognized with the “Emerging Mid-Sized Enterprise Award”

Hepanamin® Shelf Life Statement